We are live on ! Find out more
Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Portfolio holdings

AUM $52.8B
1-Year Est. Return 58.98%
This Fund
S&P 500
This Quarter Est. Return
+1.73%
1 Year Est. Return
+58.98%
3 Year Est. Return
+167.96%
5 Year Est. Return
+202.28%
10 Year Est. Return
+627.19%
AUM
$22.9B
AUM Growth
+$801M
Cap. Flow
+$1.26B
Cap. Flow %
5.48%
Top 10 Hldgs %
26.16%
Holding
1,655
New
269
Increased
651
Reduced
446
Closed
272

Top Buys

Rank Stock Value
1
FNV icon
Franco-Nevada
FNV
+$159M
2
TRP icon
TC Energy
TRP
+$105M
3
MRVL icon
Marvell Technology
MRVL
+$92.4M
4
INFY icon
Infosys
INFY
+$83.4M
5
PAAS icon
Pan American Silver
PAAS
+$81.1M

Sector Composition

Rank Sector Weight
1 Financials 23.76%
2 Technology 17.69%
3 Industrials 12.67%
4 Energy 11.54%
5 Materials 11.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HSTM icon
876
HealthStream
HSTM
$829M
$1.25M 0.01%
38,998
+10,382
+36% +$337K
BBIO icon
877
BridgeBio Pharma
BBIO
$16.4B
$1.25M 0.01%
+36,207
New +$1.22M
QCOM icon
878
Qualcomm
QCOM
$173B
$1.24M 0.01%
8,102
-158,439
-95% -$25.8M
GAU
879
Galiano Gold
GAU
$547M
$1.24M 0.01%
1,006,324
-31,500
-3% -$38.7K
WFG icon
880
West Fraser Timber
WFG
$5.5B
$1.24M 0.01%
16,100
-301,147
-95% -$24.8M
SSTI icon
881
SoundThinking
SSTI
$107M
$1.24M 0.01%
72,931
+2,198
+3% +$32.5K
PLX icon
882
Protalix BioTherapeutics
PLX
$190M
$1.24M 0.01%
+482,875
New +$1.15M
NTST
883
NETSTREIT Corp
NTST
$2.08B
$1.24M 0.01%
77,943
+1,115
+1% +$16.3K
DOO
884
Bombardier Recreational Products
DOO
$4.69B
$1.24M 0.01%
36,576
-84,700
-70% -$3.72M
TSAT icon
885
Telesat
TSAT
$934M
$1.22M 0.01%
65,053
+17,133
+36% +$327K
REGN icon
886
Regeneron Pharmaceuticals
REGN
$82.2B
$1.22M 0.01%
1,917
+983
+105% +$676K
CAC icon
887
Camden National
CAC
$990M
$1.2M 0.01%
29,646
+5,074
+21% +$219K
MOMO
888
Hello Group
MOMO
$867M
$1.2M 0.01%
189,576
+164,040
+642% +$1.19M
PPTA
889
Perpetua Resources
PPTA
$3.16B
$1.2M 0.01%
112,000
-10,500
-9% -$113K
LXFR icon
890
Luxfer Holdings
LXFR
$457M
$1.19M 0.01%
100,570
-13,815
-12% -$181K
ESPR
891
DELISTED
Esperion Therapeutics
ESPR
$1.18M 0.01%
822,618
-109,390
-12% -$202K
NGVC icon
892
Vitamin Cottage Natural Grocers
NGVC
$632M
$1.18M 0.01%
29,457
-4,251
-13% -$178K
FMNB icon
893
Farmers National Banc Corp
FMNB
$957M
$1.18M 0.01%
90,710
-6,269
-6% -$85.7K
BUD icon
894
AB InBev
BUD
$156B
$1.18M 0.01%
+19,206
New +$1.05M
HAFC icon
895
Hanmi Financial
HAFC
$956M
$1.17M 0.01%
51,585
-30,718
-37% -$711K
CHGG icon
896
Chegg
CHGG
$88.9M
$1.17M 0.01%
1,828,028
+133,506
+8% +$165K
PFBC icon
897
Preferred Bank
PFBC
$1.26B
$1.16M 0.01%
13,912
-2,882
-17% -$250K
MDB icon
898
MongoDB
MDB
$38B
$1.16M 0.01%
6,631
-2,230
-25% -$543K
TBCH
899
Turtle Beach Corp
TBCH
$230M
$1.16M 0.01%
81,259
-41,266
-34% -$688K
BOKF icon
900
BOK Financial
BOKF
$8.85B
$1.16M 0.01%
11,107
-562
-5% -$60.4K

Similar funds

Connor, Clark & Lunn Investment Management (CC&L)'s Q1 2025 Portfolio in Review

As of Q1 2025, Connor, Clark & Lunn Investment Management (CC&L) held 1,655 positions worth $22.9B, up 3.6% from $22.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Connor, Clark & Lunn Investment Management (CC&L) deployed $1.26B of net new capital in Q1 2025, opening 269 new positions and adding to 651 existing holdings. Its largest new stake was Advanced Micro Devices: 709,028 shares worth $72.8M.

By sector, the portfolio is most concentrated in Financials at 24% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Celestica, an estimated $111M trimmed.

  • Connor, Clark & Lunn Investment Management (CC&L)'s largest Q1 2025 buy was Advanced Micro Devices: 709,028 shares worth $72.8M.
  • Connor, Clark & Lunn Investment Management (CC&L) added most to Franco-Nevada in Q1 2025, an estimated $159M increase.
  • Connor, Clark & Lunn Investment Management (CC&L)'s biggest Q1 2025 reduction was Celestica, cutting an estimated $111M.
  • Connor, Clark & Lunn Investment Management (CC&L) fully exited Edwards Lifesciences in Q1 2025, selling an estimated $28.1M.
  • Connor, Clark & Lunn Investment Management (CC&L)'s ten largest holdings make up 26% of its $22.9B portfolio in Q1 2025.
  • Connor, Clark & Lunn Investment Management (CC&L) opened 269 new positions and closed 272 in Q1 2025.
  • Connor, Clark & Lunn Investment Management (CC&L)'s portfolio value rose 3.6% quarter-over-quarter to $22.9B.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q1 2025, filed 12 May 2025.